Oral Oncology
Volume 46, Issue 3 , Pages 178-184 , March 2010

Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma – In vitro and in vivo studies

  • Ling-Chang Shen

      Affiliations

    • Institute of Biotechnology, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Yuk-Kwan Chen

      Affiliations

    • Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Division of Dentistry, Department of Oral Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • Corresponding Author InformationCorresponding authors. Addresses: Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Tel.: +886 6 2757575x65600; fax: +886 6 2766505 (Y.-K. Chen), Institute if Biotechnology, National Cheng Kung University, No. 1, University Raod, 701, Tainan, Taiwan (S.-Y. Shaw).
    • ,
  • Li-Min Lin

      Affiliations

    • Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • Division of Dentistry, Department of Oral Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Shyh-Yu Shaw

      Affiliations

    • Institute of Biotechnology, National Cheng Kung University, Tainan, Taiwan
    • Corresponding Author InformationCorresponding authors. Addresses: Department of Oral Pathology, Faculty of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Tel.: +886 6 2757575x65600; fax: +886 6 2766505 (Y.-K. Chen), Institute if Biotechnology, National Cheng Kung University, No. 1, University Raod, 701, Tainan, Taiwan (S.-Y. Shaw).

Received 26 October 2009 ,Revised 25 November 2009 ,Accepted 25 November 2009.

References 

  1. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol. 1999;35:173–179
  2. Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL, Adler-Storthz K, et al. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer. 2002;95:1663–1672
  3. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer. 1997;80:1529–1537
  4. Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol. 2003;36:128–137
  5. Kodate M, Kasai T, Hashimoto H, Yasumoto K, Iwata Y, Manabe H. Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol Int. 1997;47:461–469
  6. Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res. 2001;7:2396–2404
  7. Heikkila P, Suojanen J, Pirila E, Vaananen A, Koivunen E, Sorsa T, et al. Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides. Int J Cancer. 2006;118:2202–2209
  8. Rosenthal EL, Matrisian LM. Matrix metalloproteases in head and neck cancer. Head Neck. 2006;28:639–648
  9. Tu G, Xu W, Huang H, Li S. Progress in the development of matrix metalloproteinase inhibitors. Curr Med Chem. 2008;15:1388–1395
  10. Golub LM, McNamara TF, Ryan ME, Kohut B, Blieden T, Payonk G, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol. 2001;28:146–156
  11. Saikali Z, Singh G. Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs. 2003;14:773–778
  12. Fife RS, Sledge GW. Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J Lab Clin Med. 1995;125:407–411
  13. Lokeshwar BL, Selzer MG, Zhu BQ, Block NL, Golub LM. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int J Cancer. 2002;98:297–309
  14. Fife RS, Sledge GW, Roth BJ, Proctor C. Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett. 1998;127:37–41
  15. Rubins JB, Charboneau D, Alter MD, Bitterman PB, Kratzke RA. Inhibition of mesothelioma cell growth in vitro by doxycycline. J Lab Clin Med. 2001;138:101–106
  16. Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T, Nagasue N. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. J Lab Clin Med. 2004;143:207–216
  17. Roy R, Yang J, Moses MA. Matrix metalloproteinases. As novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncal. 2009;27:5287–5297
  18. Chen YJ, Jin YT, Shieh DB, Tsai ST, Wu LW. Molecular characterization of angiogenic properties of human oral squamous cell carcinoma cells. Oral Oncol. 2002;38:699–705
  19. Mace AT, Harrow SJ, Ganly I, Brown SM. Cytotoxic effects of the oncolytic herpes simplex virus HSV1716 alone and in combination with cisplatin in head and neck squamous cell carcinoma. Acta Otolaryngol. 2007;127:880–887
  20. Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res. 1993;53:4493–4498
  21. Yang SF, Yang WE, Chang HR, Chu SC, Hsieh YS. Luteolin induces apoptosis in oral squamous cancer cells. J Dent Res. 2008;87:401–406
  22. Sigounas G, Sallah S, Sigounas VY. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model. Cancer Lett. 2004;214:171–179
  23. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993;73:161–195
  24. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54:258–265
  25. Wakai K, Ohmura E, Satoh T, Murakami H, Isozaki O, Emoto N, et al. Mechanism of inhibitory actions of minocycline and doxycycline on ascitic fluid production induced by mouse fibrosarcoma cells. Life Sci. 1994;54:703–709
  26. Bjornland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O, Maelandsmo GM. Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res. 2005;127:151–156
  27. Seftor RE, Seftor EA, De Larco JE, Kleiner DE, Leferson J, Stetler-Stevenson WG, et al. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis. 1998;16:217–225
  28. Li R, Luo X, Archer DF, Chegini N. Doxycycline alters the expression of matrix metalloproteases in the endometrial cells exposed to ovarian steroids and pro-inflammatory cytokine. J Reprod Immunol. 2007;73:118–129
  29. Liu J, Xiong W, Baca-Regen L, Nagase H, Baxter BT. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells. J Vasc Surg. 2003;38:1376–1383
  30. Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, et al. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Oncology. 2008;75:49–59
  31. Chang K, Rani AS, Kumar S. Plasminogen activator activity is decreased in rat gingiva during diabetes. J Periodontol. 1996;67:743–747
  32. Sun BC, Zhang SW, Qi LS, Zhang DF, Guo H, Zhao XL. Study on the molecular mechanism of endostatin and doxycycline in suppressing melanoma growth. Zhonghua Bing Li Xue Za Zhi. 2006;35:677–680
  33. Sun B, Zhang S, Zhang D, Yin X, Wang S, Gu Y, et al. Doxycycline influences microcirculation patterns in B16 melanoma. Exp Biol Med. 2007;232:1300–1307

PII: S1368-8375(09)00982-8

doi: 10.1016/j.oraloncology.2009.11.013

Oral Oncology
Volume 46, Issue 3 , Pages 178-184 , March 2010

Article Tools

* Image Usage & Resolution